Conference
Safety and Efficacy of First-Line Nivolumab (NIVO; Anti-Programmed Death-1 [PD-1]) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC)
Authors
Rizvi NA; Gettinger SN; Goldman JW; Hellmann MD; Chow LQ; Juergens R; Borghaei H; Brahmer JR; Shen Y; Harbison C
Volume
10
Pagination
pp. S176-S176
Publisher
ELSEVIER SCIENCE INC
Publication Date
September 1, 2015
Conference proceedings
JOURNAL OF THORACIC ONCOLOGY
Issue
9
ISSN
1556-0864